Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 6181-6185

  Längle Rouault, Françoise ^a,c   Patzel, Volker ^b   Benavente, Annie ^a   Taillez, Martine ^a   Silvestre, Nathalie ^a   Bompard, Albine ^a   Sczakiel, Georg ^b   Jacobs, Eric ^a   Rittner, Karola ^a  

^a TRANSGENE S A   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PLASMID VECTOR; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SEQUENCE ANALYSIS; VIRUS INFECTIVITY;

EID: 0031746208     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.6181-6185.1998     Document Type: Article

References (27)

1. Ambinder, R. F., W. A. Shah, D. R. Rawlins, G. S. Hayward, and S. D. Hayward. 1990. Definition of the sequence requirements of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 64:2369-2379.
2. Ambinder, R. F., M. Mullen, Y. Chang, G. S. Hayward, and D. S. Hayward. 1991. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65:1466-1478.
3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-209.
4. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Haesler, B. Fleckenstein, and W. Schaffner. 1958. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
5. Dean, D. 1997. Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res. 230:293-302.
6. DeWet, J. R., K. V. Wood, M. DeLuca, D. R. Helsinki, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725-737.
7. Dowty, M. E., P. Williams, G. Zhang, J. E. Hagstrom, and J. A. Wolff. 1995. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc. Natl. Acad. Sci. USA 92:4572-4576.
8. Evans, T. J., L. Brooks, and P. J. Farrell. 1997. A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers. Gene Ther. 4:264-267.
9. Fischer, N., E. Kremmer, G. Lautscham, N. Mueller-Lantzsch, and F. A. Grässer. 1997. Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter Karyopherin α2. J. Biol. Chem. 272:3999-4005.
10. Fresen, K.-O., B. Merkt, G. W. Bornkamm, and H. zur Hausen. 1977. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction. Int. J. Cancer 19:317-323.
11. Gahn, T. A., and C. L. Schildkraut. 1989. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58:527-535.
12. Gahn, T. A., and B. Sugden. 1995. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
13. Gautier, C., M. Mehtali, and R. Lathe. 1989. A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res. 17:8389.
14. Görlich, D., and I. W. Mattaj. 1996. Nucleocytoplasmic transport. Science 271:1513-1518.
15. Graessmann, M., J. Menne, M. Liebler, I. Graeber, and A. Graessmann. 1989. Helper activity for gene expression, a novel function of the SV40 enhancer. Nucleic Acids Res. 17:6603-6612.
16. Graham, F. L., J. Smiley, W. C. Russel, and R. Nairu. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-77.
17. Klein, G., B. Sugden, W. Leibold, and J. Menézes. 1974. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology 3:232-244.
18. Puglielli, M. T., M. Woisetschlaeger, and S. H. Speck. 1996. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J. Virol. 70:5758-5768.
19. Reisman, D., J. Yates, and B. Sugden. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822-1832.
20. Reisman, D., and B. Sugden. 1986. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
21. Sugden, B., and N. Warren. 1989. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63:2644-2649.
22. Wilson, J. B., J. L. Bell, and A. J. Levine. 1996. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15:3117-3125.
23. Wolff, J. A. 1997. Naked DNA transport and expression in mammalian cells. Neuromuscular Disorders 7:314-318.
24. Wysokenski, D. A., and J. L. Yates. 1989. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63:2657-2666.
25. Yates, J. L., N. Warren, and B. Sugden. 1985. Plasmids derived from Epstein-Barr virus replicate stably in a variety of mammalian cells. Nature 313: 812-815.
26. Yates, J. L., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483-488.
27. Zabner, J., A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh. 1995. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:18997-19007.